WANG HUIMIN 4
4 · Edwards Lifesciences Corp · Filed Jul 8, 2022
Insider Transaction Report
Form 4
WANG HUIMIN
CVP, Japan & Intercontinental
Transactions
- Sale
Common Stock
2022-07-08$97.60/sh−3,675$358,680→ 99,381.278 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2022-07-08−3,675→ 25,725 totalExercise: $35.20From: 2016-06-12Exp: 2023-05-11→ Common Stock (3,675 underlying) - Exercise/Conversion
Common Stock
2022-07-08$35.20/sh+3,675$129,348→ 103,056.278 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022.